AQR Capital Management
SMTI icon

AQR Capital Management’s Sanara MedTech SMTI Stock Holding History

AQR Capital Management’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.65M Buy
112,207
+72,269
+181% +$1.49M ﹤0.01% 2432
2026
Q1 		$686K Buy
+39,938
New +$822K ﹤0.01% 2971

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AQR Capital Management's SMTI Position: Q2 2026 in Review

AQR Capital Management increased its Sanara MedTech (SMTI) stake by 181% in Q2 2026, buying an estimated $1.49M and bringing the position to 112,207 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2432.

AQR Capital Management first reported a position in SMTI in Q1 2026 and has held it in 2 quarters since. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • AQR Capital Management held 112,207 shares of Sanara MedTech worth $2.65M as of Q2 2026.
  • AQR Capital Management bought 72,269 Sanara MedTech shares in Q2 2026, an estimated $1.49M.
  • Sanara MedTech made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #2432 holding.
  • AQR Capital Management first reported a position in Sanara MedTech in Q1 2026 and has held it in 2 quarters since.
  • 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.